by admin | Aug 7, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By inside Precision Medicine Just after 8:30 ET on Tuesday night a Commercial Resupply Services mission to the International Space Station (ISS) launched carrying 20 payloads of a diverse set of research projects to determine the benefits of working in microgravity....
by admin | Aug 4, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Dr. Prajakta Banik – Tech Explorist Cell therapy, a promising approach to treating various diseases, involves harnessing the power of a patient’s immune cells to target and destroy specific harmful cells, such as cancerous ones. However, a significant...
by admin | Aug 3, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Nature Organoids are three-dimensional structures of self-assembled cell aggregates that mimic anatomical features of in vivo organs and can serve as in vitro miniaturized organ models for drug testing. The most efficient way of studying drug toxicity and efficacy...
by admin | Aug 2, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by John Knox – Stanford Medicine News If you can imagine the entire population of Fresno, California wiped out, then you can understand what it means to say that more than half a million people will die in the U.S this year from lung cancer. It’s the leading...
by admin | Aug 1, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
The new experimental cell therapy is part of a national clinical trial aimed at eliminating seizures By Annie Pierce – UC San Diego Today In what could lead to a revolutionary advancement in the treatment of temporal lobe epilepsy, UC San Diego Health has become...
by admin | Jul 31, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Neuroscience.com Researchers embarked on a groundbreaking clinical trial involving the injection of regenerative cells into the brain to treat epileptic seizures. This experimental therapy, called NRTX-1001, has the potential to offer drug-resistant temporal lobe...
